Patterns of Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy for Low-risk Men

被引:2
作者
Chalfin, Heather J. [1 ]
Feng, Zhaoyong [1 ]
Trock, Bruce J. [1 ]
Partin, Alan W. [1 ]
机构
[1] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
关键词
CANCER-DATA-BASE; LYMPHADENECTOMY; NOMOGRAM; GROWTH;
D O I
10.1016/j.urology.2017.01.037
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To examine nationwide patterns of lymph node dissection (LND) in men with D'Amico lowrisk prostate cancer, including the rate of detected lymph node metastasis and factors associated with the decision to perform LND. Existing guidelines recommend against LND at the time of radical prostatectomy (RP) in low-risk men, yet this is still a common practice. MATERIALS AND METHODS The 2013 National Cancer Database includes 1,208,180 cases of prostate cancer diagnosed between 2004 and 2013. Of these, 50,245 met D'Amico low-risk criteria, had complete clinicopathologic data, and underwent RP. Mixed effects multivariable logistic regression models were used to identify hospital and treatment characteristics independently associated with LND, extended LND, and the detection of lymph node metastasis. RESULTS A total of 20,556 men (40.9%) underwent LND and 4360 (8.7%) had extended LND. Lymph node metastasis was present in 76 cases (0.37%). On multivariable analysis, robotic vs open RP had odds ratio (OR) = 0.16 (0.14-0.17), P <.0001, for LND, and surgery at an academic center had OR = 1.76 (1.33-2.33), P <.0001, for LND. Men on Medicaid were less likely than the privately insured to undergo LND, and the highest earners were most likely to undergo LND. In multivariable analysis, race was significantly associated with lymph node metastasis, with black men having the highest rates (P <.0001). CONCLUSION LND is performed in nearly half of low-risk men, more commonly during open surgery at academic centers, yet metastasis is discovered less than 1% of the time. Guidelines suggest that percentage core involvement should be considered, but if the overall risk of metastasis is low, LND should not be performed. (C) 2017 Elsevier Inc.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 15 条
[1]  
[Anonymous], PSA TESTING PRETREAT
[2]   Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores [J].
Briganti, Alberto ;
Larcher, Alessandro ;
Abdollah, Firas ;
Capitanio, Umberto ;
Gallina, Andrea ;
Suardi, Nazareno ;
Bianchi, Marco ;
Sun, Maxine ;
Freschi, Massimo ;
Salonia, Andrea ;
Karakiewicz, Pierre I. ;
Rigatti, Patrizio ;
Montorsi, Francesco .
EUROPEAN UROLOGY, 2012, 61 (03) :480-487
[3]   Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Fondurulia, J ;
Chen, MH ;
Kaplan, I ;
Beard, CJ ;
Tomaszewski, JE ;
Renshaw, AA ;
Wein, A ;
Coleman, CN .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :168-172
[4]   Lymphoceles Post-Radical Retropubic Prostatectomy: A Retrospective Evaluation of Epidemiology, Risk Factors and Outcome [J].
Heers, Hendrik ;
Laumeier, Tobias ;
Olbert, Peter J. ;
Hofmann, Rainer ;
Hegele, Axel .
UROLOGIA INTERNATIONALIS, 2015, 95 (04) :400-405
[5]   Changing patterns of pelvic lymphadenectomy for prostate cancer:: Results from CaPSURE™ [J].
Kawakami, Jun ;
Meng, Maxwell V. ;
Sadetsky, Natalia ;
Latini, David M. ;
Duchane, Janeen ;
Carroll, Peter R. .
JOURNAL OF UROLOGY, 2006, 176 (04) :1382-1386
[6]  
Menck HR, 1997, CANCER, V80, P2296, DOI 10.1002/(SICI)1097-0142(19971215)80:12<2296::AID-CNCR11>3.0.CO
[7]  
2-P
[8]   Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer? [J].
Mitsuzuka, Koji ;
Koie, Takuya ;
Narita, Shintaro ;
Kaiho, Yasuhiro ;
Yoneyama, Takahiro ;
Kawamura, Sadafumi ;
Tochigi, Tatsuo ;
Ohyama, Chikara ;
Habuchi, Tomonori ;
Arai, Yoichi .
INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (11) :1092-1096
[9]   Prostate Cancer, Version 1.2016 Featured Updates to the NCCN Guidelines [J].
Mohler, James L. ;
Armstrong, Andrew J. ;
Bahnson, Robert R. ;
D'Amico, Anthony Victor ;
Davis, Brian J. ;
Eastham, James A. ;
Enke, Charles A. ;
Farrington, Thomas A. ;
Higano, Celestia S. ;
Horwitz, Eric M. ;
Hurwitz, Michael ;
Kane, Christopher J. ;
Kawachi, Mark H. ;
Kuettel, Michael ;
Lee, Richard J. ;
Meeks, Joshua J. ;
Penson, David F. ;
Plimack, Elizabeth R. ;
Pow-Sang, Julio M. ;
Raben, David ;
Richey, Sylvia ;
Roach, Mack, III ;
Rosenfeld, Stan ;
Schaeffer, Edward ;
Skolarus, Ted A. ;
Small, Eric J. ;
Sonpavde, Guru ;
Srinivas, Sandy ;
Strope, Seth A. ;
Tward, Jonathan ;
Shead, Dorothy A. ;
Freedman-Cass, Deborah A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (01) :19-30
[10]   The National Cancer Data Base: Ten years of growth and commitment [J].
Partridge, EE .
CA-A CANCER JOURNAL FOR CLINICIANS, 1998, 48 (03) :131-+